Measuring VLDL1 secretion in humans with an intravenous fat emulsion test

STAR Protoc. 2023 Mar 17;4(1):102089. doi: 10.1016/j.xpro.2023.102089. Epub 2023 Feb 9.

Abstract

Tracer techniques to assess very-low-density lipoprotein (VLDL) secretion in humans are expensive, are time consuming, and require mathematical models to estimate VLDL kinetics. Here, we describe an alternative, time- and cost-efficient protocol to directly determine VLDL1 secretion with an intravenous (i.v.) lipid emulsion test that does not require tracers and compartmental modeling. We describe steps for intralipid infusion, blood sampling, and removal of intralipid from plasma samples, followed by density gradient ultracentrifugation to isolate VLDL1 fraction and measure the secretion rate. For complete details on the use and execution of this protocol, please refer to Bjorkegren et al. (1996),1 Al-Shayji et al. (2007),2 and Metz et al. (2022).3.

Keywords: Chemistry; Clinical Protocol; Metabolism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Fat Emulsions, Intravenous*
  • Humans
  • Lipoproteins, VLDL*

Substances

  • Lipoproteins, VLDL
  • Fat Emulsions, Intravenous